Subscribe

Spotlight -

Community/Retail|

Pharmacy Technician|

Connor M. Bunch, MD

Articles by Connor M. Bunch, MD

Clostridium Difficile Infection -- Image credit: syahrir | stock.adobe.com

Impact of Pharmacist-Led Initiatives on Health Care–Associated Clostridioides difficile Rates

ByLaura Gillespie, PharmD,Yassmeen Marzuq, PharmD,Anthony V. Thomas, BS,Connor M. Bunch, MD

March 14th 2024

Antimicrobial stewardship efforts focusing on accurate penicillin allergy histories, β-lactam cross-reactivity education, and guideline-driven narrow-spectrum prescribing may help sustainably decrease health care–associated Clostridioides difficile infection rates.

Latest Updated Articles

Study: How Individual Carbohydrate Responses Reveal Metabolic Health and Potential Biomarkers
Published: June 12th 2025 | Updated: June 16th 2025
Department of Health and Human Services Reconstitutes ACIP, Removing 17 Sitting Members
Published: June 10th 2025 | Updated: June 12th 2025
NLA 2025: Managing Omega-3 Therapy With Statins, PCSK9 Inhibitors for Cardiovascular Care
Published: June 2nd 2025 | Updated: June 11th 2025
ASCO 2025: Zongertinib Shows Strong Potential in HER2-Mutant NSCLC Treatment Landscape
Published: June 3rd 2025 | Updated: June 11th 2025
Emerging Data: Impacts of ROCKstar and AGAVE-201
Published: May 30th 2025 | Updated: June 5th 2025
Measles Cases Climb to 800 in United States as Outbreak Spreads Across Borders
Published: April 18th 2025 | Updated: April 21st 2025

Trending on Pharmacy Times - Pharmacy Practice News and Expert Insights

Elranatamab Plus Daratumumab and Lenalidomide Yields Durable Responses, Manageable Safety

NCCN Guideline Update in SCLC Adds Maintenance Lurbinectedin, Removes Chemotherapy-Free Interval

IMS 2025: Improving Outcomes with Bispecifics in Multiple Myeloma

Effectively Managing Immunizations in the Long-Term Care Setting

New Teclistamab Study in Multiple Myeloma Shows Improved Tolerance, Responses

© 2025 MJH Life Sciences^®

All rights reserved.